Trial of Apremilast for Oral Ulcers in Behçet’s Syndrome

Abstract Background The small-molecule phosphodiesterase 4 inhibitor apremilast modulates cytokines that are up-regulated in Behcet’s syndrome. In a phase 2 trial involving patients with Behcet’s s...